Search

everythinglearnresearchcommunity

for

Search:↓

The document explains the genetic causes and characteristics of inherited hair disorders.

New cytokine-targeted therapies show promise for treating alopecia areata.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Systemic lupus erythematosus is diagnosed earlier in males than females.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

The treatment was effective for the puppy's skin and intestinal infections.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The dog with severe hair loss and itching improved after treatment for ehrlichiosis and demodicosis.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Baricitinib may effectively treat oral lichen planus.

Histone modification is key in treating chronic inflammatory skin diseases.

Fever and rash can be early signs of lupus.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Targeting NETs may help reduce fibrosis in Crohn's disease.